Recommended

Download this feature partnership: Continuous manufacturing: an evolving technology for drug substance manufacturing

New webinar: Defining the right digital strategy for oncology: What do you want to measure?

Join now: Pharmaceutical continuous manufacturing: what’s next for industry?

Register now for our upcoming webinar: Enhancing oral drug delivery: Exploring multiparticulate systems

Download our latest in-depth focus to read articles on single temperature incubation, endotoxin standards and aseptic connections in pharma manufacturing.

Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps

Register now: Simplifying complex dosage forms with advanced encapsulation

Join our webinar: Unmasking the unknown: how mass spectrometry delivers accurate identifications

<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-P89LTFL" height="0" width="0" style="display:none;visibility:hidden"></iframe>

List view / Grid view

Biogen Idec

Biogen Idec sells BENLYSTA royalty rights to DRI Capital managed fund

10 September 2012 | By Biogen Idec

Biogen Idec has sold to a DRI Capital managed fund its royalty and other rights relating to BENLYSTA®...

Biogen Idec Foundation donates $100,000 to launch STEM education collaboration with Teach for America

17 August 2012 | By Biogen Idec

New collaboration in support of Science, Technology, Engineering, and Math education...

Biogen Idec announces collaboration with leading research institutions to sequence genomes of patients with ALS

17 July 2012 | By Biogen Idec

Labs at Duke University and HudsonAlpha Institute to lead research consortium...

Biogen Idec and SOBI initiate global clinical trials of long-lasting hemophilia A and B product candidates in children

5 July 2012 | By Biogen Idec

Biogen Idec and SOBI announced the initiation of two global pediatric clinical trials...

Biogen Idec and Isis announce global collaboration for antisense program targeting myotonic dystrophy

29 June 2012 | By Biogen Idec

Isis expands its rare disease franchise to include DM1...

Biogen Idec continues support for MS community with worldwide celebrations on Fourth Annual World MS Day

30 May 2012 | By Biogen Idec

Biogen Idec will join with the MS community around the world...

New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine

18 May 2012 | By Biogen Idec / Elan Corporation plc

Use of biomarker has potential to advance personalised treatment for MS patients...

New AVONEX® dosing innovations for people with Multiple Sclerosis now available in US

14 May 2012 | By Biogen Idec

Two new dosing innovations designed to help patients receiving once-a-week AVONEX...

US and EU regulatory authorities accept oral BG-12 marketing applications for review

9 May 2012 | By Biogen Idec

U.S. and EU regulatory authorities have accepted marketing applications for review...

FDA approves AVONEX PEN and dose titration regimen

28 February 2012 | By

Dosing enhancements may improve treatment experience for patients receiving AVONEX® (interferon beta-1a) for MS...

Biogen Idec submits application to FDA for approval of oral BG-12 to treat multiple sclerosis

28 February 2012 | By Biogen Idec

EMA submission anticipated within the coming days...

Samsung Biologics and Biogen Idec announce formation of biosimilars joint venture Samsung Bioepis

27 February 2012 | By Biogen Idec

Samsung Biologics & Biogen Idec have established their joint venture...

Biogen Idec to acquire Stromedix

14 February 2012 | By Biogen Idec

Biogen Idec and Stromedix, Inc. announced that they have entered into a definitive agreement under which Biogen Idec will acquire Stromedix Inc...

Biogen Idec appoints Kenneth DiPietro Executive Vice President Human Resources

30 January 2012 | By Biogen Idec

Kenneth DiPietro named Executive Vice President, Human Resources...

ASCEND study to evaluate the effectiveness of TYSABRI® (natalizumab) as a treatment for SPMS

26 January 2012 | By Biogen Idec

Biogen Idec and Elan Corporation, plc announced a global Phase 3b study, ASCEND, that is being conducted to evaluate the effectiveness of TYSABRI as a treatment for SPMS...

© Russell Publishing Limited, 2010-2024. All rights reserved.

Website development by e-Motive Media Limited.

Cookie Settings

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Advertising & Targeting

Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.